Your briefing

Jim Cramer Highlights CrowdStrike is “Winning Huge Deals”
Finance 2 weeks ago
Jim Cramer Highlights CrowdStrike is “Winning Huge Deals”
Full Coverage

Anti-Trump rock star’s vow to ditch politics at shows doesn’t seem to last very long
The 1975's Matty Healy told Glastonbury fans the band would move away from politics, but contradicted this by displaying political imagery during thei...
Headlines 2 weeks ago
Anti-Trump rock star’s vow to ditch politics at shows doesn’t seem to last very long
Full Coverage

Jim Cramer on AST SpaceMobile: “Gotta Ring the Register a Little”
Finance 2 weeks ago
Jim Cramer on AST SpaceMobile: “Gotta Ring the Register a Little”
Full Coverage

Jim Cramer Says Applied Digital is a “Very Good Spec”
Finance 2 weeks ago
Jim Cramer Says Applied Digital is a “Very Good Spec”
Full Coverage

Trending

1. Joann's closing
2. Texas Tech basketball
3. UNC basketball
4. Monster Hunter Wilds
5. Ketamine
6. Macron
7. UPMC Memorial shooting
8. Eagles
9. Hims stock
10. Joel Embiid

Popular News

BrightGene präsentiert positive Phase-2-Daten für den Dual-G...
3 weeks ago
BrightGene präsentiert positive Phase-2-Daten für den Dual-GLP-1R/GIPR-Agonisten zur Gewichtsregulation und Behandlung von Typ-2-Diabetes sowie präklinische Daten für ein neues Amylin-Analogon bei den 85 Wissenschaftlichen Sitzungen der American Diabetes Association

The mortgage market hopes for rate cuts amid war moves
3 weeks ago
The mortgage market hopes for rate cuts amid war moves

Ukraine returns bodies of 3 Russian soldiers repatriated as ...
3 weeks ago
Ukraine returns bodies of 3 Russian soldiers repatriated as remains of Ukrainians, Interior Ministry says

BrightGene presenteert positieve fase 2 gegevens voor de dua...
3 weeks ago
BrightGene presenteert positieve fase 2 gegevens voor de duale GLP-1R/GIPR agonist voor gewichtsbeheersing en type 2 diabetes, en preklinische gegevens voor een nieuw amylin-analoog tijdens de 85e wetenschappelijke sessies van de American Diabetes Association

BrightGene présente des données positives de phase 2 pour so...
3 weeks ago
BrightGene présente des données positives de phase 2 pour son agoniste double GLP-1R/GIPR dans la gestion du poids et le diabète de type 2, ainsi que des données précliniques pour un nouvel analogue de l'amylin, lors de la 85 e édition des Sessions Scientifiques de l'American Diabetes Association
About Us · Contact Us · Terms & Conditions · Help · Privacy ·

© Latest News Search Engine - Global and Local Breaking News 2025. All rights are reserved